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Introduction
The cerebellum is a major site for tissue injury in multiple sclerosis (MS), particularly in patients with progressive disease (Calabrese et al., 2010; Kutzelnigg et al., 2007; Redondo et al., 2014) .
Indeed, cerebellar dysfunction in MS is a significant contributor to disability, commonly progressing regardless of treatment with disease-modifying agents (Waxman, 2005) . Cerebellar dysfunction in MS is thought to arise due to a combination of white matter (WM) and grey matter (GM) injury, similar to that which occurs elsewhere in the cerebral cortex and underlying white matter tracts. The role of GM injury in MS has received less attention than WM injury, yet pathological studies of MS GM have revealed evidence for extensive demyelination, inflammation and neuronal loss (Kutzelnigg et al., 2005; Lucchinetti et al., 2011; Mahad et al., 2008) . Furthermore, cortical atrophy on MRI scans is a well-recognised feature of established progressive disease (Steenwijk et al., 2016) . Understanding the causes of MS GM injury in the cerebellum may help design therapies to reduce injury in this part of the brain.
A major role for reactive oxygen species (ROS) in the pathophysiology of MS and central nervous system (CNS) inflammatory disorders has been demonstrated (Cross et al., 1998; Smith et al., 1999; van Horssen et al., 2011) . An imbalance in cellular redox homeostasis, leading to oxidative stress, may be caused by a large number of biological mechanisms resulting in the overproduction of ROS (Murphy, 2009) . Changes leading to high concentrations of ROS have the potential to cause tissue damage and cell death within the CNS (Haider et al., 2011) .
Increases in ROS also trigger the formation of toxic molecules, such as lipid peroxidation products (Keller and Mattson, 1998) , which themselves are strong reactive electrophiles capable of perpetuating oxidative stress (Abarikwu et al., 2012; Matveychuk et al., 2011) .
Experimentally, ROS and their reactive products cause cellular injury to neurons (and their axons) and oligodendrocytes (Abarikwu et al., 2012; French et al., 2009; Li et al., 2005; Wilkins and Compston, 2005) .In both pathological studies and animal models of CNS inflammation, ROS play a key role in promoting tissue damage (Cross et al., 1998; Haider et al., 2011; Smith et al., 1999; van Horssen et al., 2008) .
There is a complex cellular interplay between oxidative injury and anti-oxidant defences, and cells possess a diverse array of mechanisms to reduce ROS that build up during normal 4 physiological processes. These include anti-oxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase (GPX) and glutathione reductase. Failure of endogenous cell protection mechanisms that operate early in the disease course is postulated to be a major reason for on-going tissue damage in MS (van Horssen et al., 2011) . Specifically, imbalances in the levels of oxidative stress molecules and anti-oxidant defences may be important in this respect, and precise identification of any imbalances may allow for the development of targeted therapeutic interventions which may help crucially tip the balance between cell death and survival. Indeed, a number of neurological conditions including amyotrophic lateral sclerosis, Xlinked adrenoleucodystrophy and adrenomyeloneuropathy all highlight the important balance between oxidative stress and anti-oxidant defences (Moser et al., 2007; Rosen, 1993) .
To date, studies have shown alterations in the levels of specific endogenous anti-oxidant enzymes and markers of oxidative stress in serum, cerebrospinal fluid (CSF) and brain tissue derived from patients with MS (Calabrese et al., 2002; Lund-Olesen, 2000; Tajouri et al., 2003; van Horssen et al., 2008) . However, a clear understanding of precise mechanisms of tissue injury in MS is lacking, particularly in key pathological sites such as the cerebellum. In this study we have studied oxidative injury and the expression of anti-oxidant molecules in MS cerebellar grey matter. 5
Results

Antibody specificity
All primary antibodies used for immuno dot-blotting were tested for their specificity against their chosen antigens using western blotting techniques. Under the experimental conditions used, all antibodies displayed specific bands as described on manufacturer data sheets and/or relative to their reported molecular weights and were therefore considered suitable for use in immuno dotblotting techniques (figures 2f, 3e, 5c).
Characterisation of cerebellar grey matter
Regions of demyelination (determined by myelin basic protein (MBP) staining) were seen in cerebellar grey matter (GM) tissue samples. Demyelination was typically seen exclusively within GM cerebellar above and below the layer of the Purkinje cells (supra-and infra-ganglionic layer) extending into the granular layer (cortical; figure 1a ); or extending from white matter into the granular layer (leucocortical). As previously reported using the same patient cohort, all MS cases (and no control cases) showed areas of cortical and leucocortical demyelination within the grey matter. 29.4% (+/-11.5 SEM) of the cerebellar cortex was demyelinated, representing 13.7% (+/-8.5 SEM) with leucocortical demyelination and 15.7% (+/-7.2 SEM) with purely cortical demyelination . Control sections immunolabelled for the macrophage/microglial marker human leucocyte antigen (HLA)-DP, DQ, DR, showed few positive cells in the cerebellum (figure 1b). In MS, HLA-DP, DQ, DR positive cells were scattered throughout cerebellar grey matter (GM) regions, where they had enlarged perikarya with thicker processes (figure 1c).
Quantification of tissue injury in cerebellar grey matter
Quantification of protein levels of HLA-DP, DQ, DR (determined by immunodot-blotting) revealed an increase (by approximately 2.5-fold) in MS cases compared to controls (Figure 2a ).
In addition immunodot-blotting of cerebellar GM tissue revealed a significant decrease in levels of MBP expression in keeping with immunohistochemical analysis of tissue (figure 2b).
Quantification of neuronal markers: microtubule-associated protein 2 (MAP2), neurofilament 6 200 (NF200) and calbindin-D28k levels by immunodot-blot analysis revealed a global reduction in all the markers tested, in MS cerebellar GM when compared to control tissue (Figure 2c -e).
Measurements of lipid peroxidation and oxidative stress
Malondialdehyde (MAL) and 4-hydroxynonenal (4-HNE) are major end-products of oxidation of polyunsaturated fatty acids, and are generally accepted as indicators of lipid peroxidation and oxidative stress (Requena et al., 1997) . MAL and 4-HNE expression in the cerebellum of both control and MS patients was also investigated using immuno dot-blot analysis and immunohistochemistry. 4-HNE levels were significantly increased in the MS cerebellum grey matter when compared to control tissue (figure 3a). However, there were no significant changes evident in MAL levels between groups (Figure 3b ).
Analysis of the relationship between 4-HNE with the corresponding anti-oxidant enzyme,
neuronal or myelin expression in MS GM, revealed a significant negative correlation between the expression of 4-hydroxynonenal and MBP (p<0.05; figure 3c ). We found no correlation between the levels of MAL and MBP (figure 3d).
Areas of cerebellar tissue were subsequently immunolabelled using antibodies against 4-HNE and MAL in the sections derived from MS and control patients. In control sections, little or no positivity was demonstrable in the cerebellum (figure 4e-h). In MS cases, 4-HNE was abundant in the grey matter, particularly in the granular layer where it was co-localised with MBP labelling (figure 4a-d). In comparison, MAL showed less reactivity within the grey matter although did show occasional expression within neurons, such as Purkinje cells (data not shown).
Anti-oxidant enzyme gene and protein expression in cerebellar grey matter derived from MS and control patients
In order to determine anti-oxidant responses to the increased lipid peroxidation product 4-HNE, an analysis of anti-oxidant enzyme expression at the genomic and proteomic level using realtime polymerase chain reaction (RT-PCR) and immuno dot-blotting techniques respectively was performed in cerebellar GM in MS cases and controls. Both SOD1 and SOD2 mRNA and protein levels differed significantly between control and MS brain tissue, with a minimal 1.5 fold 7 increase in SOD expression in the MS brain (figures 5a,b). However, there were no significant changes evident in either catalase or GPX mRNA or protein levels between patient groups.
To investigate the cellular localisation of both SOD1 and SOD2 within the cerebellum grey matter, MS tissue was double immunolabelled using antibodies to either SOD1 or SOD2 in conjunction with HLA-DP, DQ, DR (figure 5d-k). In MS sections, neuronal localisation of both SOD1 and SOD2 expression was evident (particulary in the Purkinje cells which were identified on the basis of their characteristic morphology), showing typical neuronal cytoplasmic and mitochondrial labelling respectively, which in turn was relatively absent in the cells labelled with the macrophage/microglial marker HLA-DP, DQ, DR. 8
Discussion
We have performed a series of experiments using human cerebellar GM tissue investigating tissue injury, lipid peroxidation and anti-oxidant enzyme expression. In MS the GM was characterised by microglial infiltration, cortical and leucortical demyelination, and a reduction in expression of neuronal markers. In addition, we show elevation of the lipid peroxidation product 4-HNE, which co-localises and negatively correlates with MBP expression in the granular layer of the cerebellum, suggesting 4-HNE may be relevant to GM demyelination in the cerebellum.
Using quantitative PCR and immunodot-blotting assays, we have shown that anti-oxidant enzyme expression in the cerebellum is altered in MS at both the mRNA and protein level. We show here that superoxide dismuting enzymes (SOD1 and SOD2), localised within cerebellar neurons, are up-regulated in MS, but the activation of subsequent enzymes responsible for the detoxification of hydrogen peroxide, both catalase and GPX, are relatively deficient.
Several studies have highlighted the extent of tissue injury in MS cerebellum. In a similar way to the cerebral cortex, the cerebellar cortex appears a major site for demyelination in MS with one study reporting 38.7% of the cerebellar cortex being affected in a cohort of PPMS and SPMS patients (Kutzelnigg et al., 2007) . It is thought that mechanisms of demyelination in the GM are similar to WM, although there may be particular topographical influences on GM demyelination.
For instance, microglial infiltration into GM in commonly seen, but recent observations have suggested an association between meningeal inflammation and pathology in the adjacent cerebral cortex (Calabrese et al., 2015; Howell et al., 2014) . The precise mechanism of GM demyelination needs further elucidation. In addition to myelin loss, other studies have previously reported neuronal changes within MS cerebellum. Purkinje cell densities in lesional cerebellar GM (compared to control) are reduced, but no significant reductions in Purkinje cell densities were seen in non-lesional GM (Kutzelnigg et al., 2007; Redondo et al., 2014) . Changes in Purkinje cell morphology and neurofilament phosphorylation states are also to demyelination . Our demonstration of global reductions in the expression of neuronal markers is in keeping with previous demonstration of neurodegenerative processes in MS.
Oxygen radical-induced cytotoxicity is associated with lipid peroxidation. By reacting with polyunsaturated fatty acids in the various cellular membranes, oxyradicals such as hydroxyl 9 (OH . ) and peroxynitrite (ONOO) give rise to a variety of lipid peroxidation products, including 4-hydroxynonenal and malondialdehyde, which are frequently measured as indicators of oxidative stress in vivo (Keller and Mattson, 1998; Requena et al., 1997) . These reactive aldehydes are themselves cytotoxic; being strong reactive electrophiles and, amongst a plethora of toxic properties, they have the capability to inhibit DNA, RNA, and protein synthesis and may disrupt protein and membrane structures (reviewed by Matveychuck et al (Matveychuk et al., 2011) ). They also have the capability to perpetuate oxidative stress by elevating mitochondrial ROS and inhibiting the antioxidant defence system through decreasing catalase, glutathione and SOD levels (Abarikwu et al., 2012; Long et al., 2009) .
A major role for ROS in the pathophysiology of MS and central nervous system inflammatory disorders has been demonstrated in both pathological and experimental studies (Cross et al., 1998; Smith et al., 1999) . Specifically, ROS may not only induce tissue injury and cellular death, but may also interfere with normal cellular functioning in the central nervous system. For instance, oxidative molecules, notably hydrogen peroxide, may disrupt oligodendrocyte maturation which may have consequences for endogenous repair mechanisms in MS (French et al., 2009 ). The enzymes responsible for the generation of ROS have been detected in tissue derived from patients with MS and experimental models of CNS inflammation. NADPH oxidase is responsible for the generation of superoxide ions and is highly expressed in activated microglia and infiltrating macrophages within MS lesions (Fischer et al., 2012) . In addition, expression of iNOS, which is responsible for the generation of nitric oxide, is up-regulated in microglia and macrophages in acute and chronic lesions and has been linked to acute axonal injury (Bagasra et al., 1995; Diaz-Sanchez et al., 2006; Hill et al., 2004; Liu et al., 2001) .
Profound oxidative damage to myelin, oligodendrocytes and neurons has also been demonstrated in MS lesions (Haider et al., 2011) . ROS activation may also be a key event in the disruption of the blood-brain barrier, an important event in MS disease initiation (Schreibelt et al., 2006; Van der Goes et al., 2001) . It is known that a number of oxidation products, including 4-HNE and oxidised phospholipids, are abundantly present in active MS lesions (Haider et al., 2011; van Horssen et al., 2008) . Haider et al. demonstrated the presence of oxidative damage in MS lesions describing oxidized DNA (8-hydroxy-D-guanosine) and lipid peroxidation-derived structures (malondialdehyde and oxidised phospholipid epitopes) (Haider et al., 2011) . We have shown that 4-HNE levels are elevated in MS cerebellar GM. Within the MS cerebellum higher levels of 4-HNE expression are associated with reduced MBP expression, and that 4-HNE appears to be colocalised with myelin predominantly in the granular cell layer, suggesting that 4-HNE production within the GM may be associated with myelin loss.
The interactions between ROS and anti-oxidant enzymes within MS tissue are complex.
Previous studies have shown changes in levels of certain endogenous anti-oxidant enzymes in MS tissue. For instance, increases in SOD1 gene transcription and protein expression have been detected in acute demyelinating MS lesions (Tajouri et al., 2003; van Horssen et al., 2008) .
These studies also showed evidence for changes in catalase expression by macrophages and some increases in GPX gene transcription (Tajouri et al., 2003; van Horssen et al., 2008) . Whole genome arrays have also suggested that GPX isoenzyme transcripts may be differentially expressed in MS lesions (Fischer et al., 2012) . Studies concerned with the determination of antioxidant enzymes in CSF of MS patients have also been limited. One small study has suggested SOD levels may be low in CSF derived from patients with MS (Lund-Olesen, 2000) . Catalase activity has been found to be elevated (Calabrese et al., 2002) and conversely GPX has also been shown to be markedly decreased (Calabrese et al., 1994) in CSF samples from patients with MS compared to control.
This current study has shown increases in mRNA and protein expression of superoxide dismuting enzymes (SOD1 and 2) with no increase in hydrogen peroxide reducing enzymes (catalase and GPX). SOD1 and SOD2 are immunocytochemically localised to cerebellar neurons, and not infiltrating macrophage/microglial cells. Imbalances in the cellular redox homeostasis (increased ROS production alongside a lack in hydrogen peroxide detoxifying enzyme activity) may lead to an excess of hydrogen peroxide and the subsequent formation of 4-HNE and/or malondialdehyde as evident in this study. In support of this theory, in vitro studies have directly correlated decreased glutathione levels and GPX activity with increased lipid peroxidation and protein carbonylation (Bizzozero et al., 2006; Bizzozero et al., 2007) . Our findings may therefore suggest that in MS the lack in activity of hydrogen peroxide detoxifying 11 enzymes during the inflammatory insult may conceivably play a pathogenic role in the accumulation of lipid peroxidation, oxidative stress and myelin injury in MS GM.
Taken together our observations provide evidence for tissue injury, lipid peroxidation and alterations in the production of protective anti-oxidant enzymes in MS GM. Generation of the lipid peroxidation product 4-HNE may be linked to myelin injury. Furthermore, imbalances in anti-oxidant enzyme expression in MS GM may be linked to abnormalities of ROS detoxification with subsequent build-up of toxic molecules causing cellular stress and irreversible tissue damage in patients with MS. Our data provide insights into oxidative and antioxidative processes occurring within the cerebellum in MS. This study suggests that directed and specific therapeutic strategies to reduce oxidative damage may play a crucial role in reducing tissue injury in MS.
Experimental procedure
Patients
Post-mortem cerebellum samples from eight patients with MS and six control patients were obtained through collaboration with the UK Multiple Sclerosis Tissue Bank at the Imperial College, London, UK. For the majority of MS cases, there were multiple tissue blocks for each patient, a total of twenty five frozen and six formalin-fixed paraffin embedded tissue blocks were therefore used in this study. All patients had been clinically diagnosed as having MS and this diagnosis had been confirmed during neuropathological autopsy examination. Control cerebellum samples were derived from patients who had died from causes other than neurological disease (Table 1) . All tissues were collected with the donors' fully informed consent via a prospective donor scheme. At death, brains were removed; and either 'snap frozen' or fixed in neutral buffered formalin and tissue blocks embedded in paraffin. Case histories for all eight MS patients were reviewed (although some were incomplete). Six out of eight were documented to have moderate to severe ataxia.
Immunohistochemistry on paraffin sections
Cerebellar sections 10 µm in thickness were immunostained with antibodies to MBP (1:3200)(Serotec, Oxford, UK) and HLA-DP DQ DR (1:800)(Dako, Cambridgeshire, UK).
Sections were deparaffinised in Clearene, dehydrated in 100% ethanol, hydrated in distilled water, and immersed in 3% hydrogen peroxide in methanol for 30 minutes to block endogenous peroxidase activity, rinsed and microwaved in sodium citrate buffer (0.01 M, pH 6.0, 5 minutes) or EDTA buffer (1 mM, pH 8, 10 minutes) as appropriate and rinsed in phosphate-buffered saline (PBS). Non-specific binding was blocked with Vectastain blocking serum (20 minutes).
After addition of the primary antibody, sections were incubated overnight at 4°C. The sections were then rinsed in PBS before incubation for 20 minutes with secondary antibody (Vectastain Biotinylated Universal antibody) and 20 minutes with VectaElite ABC Complex (PK-6200, Vector Laboratories, Peterborough, UK) followed by a 10-minute incubation with 3,3′diaminobenzidine (DAB) and 0.01% H2O2. Sections were washed in water, immersed in copper sulphate DAB enhancer (4 minutes), counterstained with hematoxylin, dehydrated, cleared and mounted. Cerebellar slices (for 6 of the MS cases) were stained with MBP and measurements of 13 the regions of demyelination in each section obtained using Image J software to obtain the percentage of demyelination per standardized unit length. Further analysis of the tissue was performed using immuno-blotting techniques described below.
Immunofluorescence labelling on paraffin sections
Sections (10µm) were deparaffinised, hydrated and washed as above. To reduce autofluorescence, sections were incubated in 5 mM copper sulphate and 50 mM ammonium acetate for 1 h at room temperature prior to microwaving in sodium citrate buffer (0.01 M, pH 6.0, 5 minutes). Cells were labelled by double immunofluorescence using antibodies to 4-Hydroxynonenal (1:500)(Abcam, UK), Malondialdehyde (1:250)(Abcam, UK), MBP
(1:100)(Serotec, Oxford, UK), HLA-DP DQ DR (1:250)(Dako, Cambridgeshire, UK), SOD1
(1:250)(Abcam, UK) and SOD2(1:250)(Abcam, UK). Non-specific binding was blocked with 10% normal goat serum diluted in PBS containing 0.1% triton. Sections were incubated at 4°C overnight with primary antibodies. Sections were then washed in PBS and incubated for 30 minutes in the dark with Alexa Fluor 488, goat anti-mouse or Alexa Fluor 555 (1:500), goat antirabbit (1:500)(Invitrogen, Paisley, UK), before being washed in PBS and mounted in Vectashield medium containing the nuclear dye 4′6′-diamidino-2-phenylindole (DAPI) (H-1200, Vector Laboratories).
Real-time Polymerase Chain Reaction (PCR)
Frozen tissue blocks were thawed on ice and grey matter carefully dissected away from white matter layers. RNA isolation, cDNA synthesis and RT-PCR were carried out as previously described by methods used within our laboratory (Gray et al., 2014; Hares et al., 2013) 
Immuno blotting
Sample preparation
Frozen tissue blocks were thawed on ice and grey matter carefully dissected away from white matter layers. The grey matter was then homogenized on ice by use of the PARIS kit (Ambion, UK) and a protease and phosphatase inhibitor cocktail (Thermo Scientific, UK) added at a dilution 1:100. The supernatants were removed and stored at −80°C until required.
Antibodies
Antibodies used were mouse anti-GAPDH (1:5000), rabbit anti-SOD1 (1:4000), mouse anti-SOD2 (1:4000), rabbit anti-catalase (1:10000), rabbit anti-GPX-1 (1:5000), rabbit antimalondialdehyde (1:6000) and mouse anti-4 hydroxynonenal (1:300)(all from Abcam, UK); mouse anti-HLA-DP DQ DR (1:1000) (Dako, Cambridgeshire, UK); rat anti-MBP (1:2000) (Serotec, Oxford, UK); rabbit anti-calbindin D28k (1:2000) , mouse anti-MAP2 (1:5000) and mouse anti-NF200 (1:10000)(all from Sigma-Aldrich, UK);
Western blotting and Immuno dot-blotting
Both western blotting and immune dot-blotting were carried out as previously described (Gray et al., 2014; Hares et al., 2013) . Densitometic analysis of protein dots was performed using ImageJ software (NIH, USA). Values were expressed relative to the loading control protein GADPH in order to give an indication of the relative expression of proteins throughout the whole tissue.
Statistical analysis
Statistical analysis was performed using a regression model using STATA v12. Where the distribution of the original variable differed significantly from normal, the regression model was fitted on the square root or log transformation of the response. The model also allowed for any correlation among multiple sections coming from the same brain tissue (cluster option). Nonparametric bootstrap was used to estimate standard errors and confidence intervals to account for possible non-normality of the parameter's distribution. Linear regression, Spearman's or Pearson's correlation methods were also used to analyse relationships between two variables.
The analysis was performed using STATA v12 (Timberlake Consultants, London, UK) and GraphPad Prism (GraphPad Software Inc, USA). For all tests, values of p<0.05 were considered statistically significant. Tables   Table 1 The 
